Análisis Argos
ZBH
ZBHEn su precio
Zimmer Biomet Holdings, Inc. · Healthcare
US$ 87.47
precio al 2026-07-04
Valor justo Argos*
US$ 87–97
vs. su valor justo
1% por debajo
Score Argos
39/100
En su precio
LA RESPUESTA
El precio asume un crecimiento (0.1%) en línea con lo que la empresa demuestra (2.1%). Ni ganga ni exceso — el mercado le puso un precio razonable.
Recompensas
Sin recompensas destacadas.
Riesgos
!Cotiza 20% por encima de su valor justo.
!Balance frágil: la deuda pesa sobre el negocio.
!Crecimiento estancado o en baja.
VALOR3/6FUTURO2/6PASADO2/6SALUD2/6DIVIDENDO4/6
El Iris de calidad
VALOR3/6FUTURO2/6PASADO2/6SALUD2/6DIVIDENDO4/6
ValorCerca de su valor justo
FuturoCrecimiento moderado
PasadoHistorial aceptable
SaludBalance razonable
DividendoDevuelve capital al accionista
Score Argos39de 100En su precio
Ingresos▲7%
US$ 8.2 B
Margen operativo▼1%
16.5%
Flujo de caja libre▲29%
US$ 1.5 B
Deuda neta
US$ 6.9 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 16.9B
P/E24x
EV/EBITDA9.7x
FCF yield8.7%
ROIC5.9%
Margen operativo16.5%
Crecim. ingresos+7.2%/año
Piotroski F5/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

zacks.com · 2 jul
Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
reuters.com · 2 jul
Medical device maker Zimmer Biomet to hire 500 in 3 years for tech centre in India
Medical device maker Zimmer Biomet plans to hire 500 employees over the next three years ​for its newly opened technology centre in Bengaluru, a senior ‌executive said, as the U.S.-listed company expands its presence in India.
zacks.com · 1 jul
Pacira to Divest iovera Business to Zimmer Biomet in Up To $140M Deal
PCRX is set to sell its iovera franchise to ZBH in a deal worth up to $140M as it sharpens focus on biopharmaceutical growth.
zacks.com · 24 jun
ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?
ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.
zacks.com · 18 jun
Why Zimmer Biomet (ZBH) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zacks.com · 16 jun
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
seekingalpha.com · 16 jun
Zimmer Biomet: Does Slow And Steady Still Win The Race?
Zimmer Biomet Holdings trades at a steep valuation discount despite strong free cash flow and high margins. ZBH's entrenched position in orthopedic implants, robust cash generation, and loyal installed base underpin reliable earnings. Recent results show net sales up 9.3%, adjusted EPS up 15.5%, and adjusted gross margin rising to 73.0%.
seekingalpha.com · 8 jun
Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.